Concomitant Liver Biopsy During Bariatric Surgery: No Increase in Major Complications or Readmissions but Associated with Higher Transfusion Requirements - An Analysis of the MBSAQIP Database - Summary - MDSpire

Concomitant Liver Biopsy During Bariatric Surgery: No Increase in Major Complications or Readmissions but Associated with Higher Transfusion Requirements - An Analysis of the MBSAQIP Database

  • By

  • Juan S. Barajas-Gamboa

  • Kayanne Khoury

  • Valentin Mocanu

  • Mélissa V. Wills

  • Thomas H. Shin

  • Gustavo Romero-Velez

  • Matthew Allemang

  • Andrew T. Strong

  • Salvador Navarrete

  • Ricard Corcelles

  • A. Daniel Guerron

  • John Rodriguez

  • Matthew Kroh

  • Jerry T. Dang

  • September 25, 2025

  • 0 min

Share

Objective:

To evaluate the 30-day rate of serious complications, including specific types of complications and mortality, associated with concomitant liver biopsy during bariatric surgery using the MBSAQIP database.

Key Findings:
  • No increase in major complications or readmissions associated with concomitant liver biopsy during bariatric surgery.
  • Higher transfusion requirements noted in patients undergoing liver biopsy, indicating a need for careful monitoring.
Interpretation:

Concomitant liver biopsy during bariatric surgery is safe in terms of major complications and readmissions, but may lead to increased transfusion needs, which should be considered in surgical planning.

Limitations:
  • Retrospective design may introduce selection bias.
  • Data limited to specific time frame and may not reflect long-term outcomes.
  • Potential confounding factors may not have been fully controlled for in the analysis.
Conclusion:

Concomitant liver biopsy during bariatric surgery does not significantly increase major complications or readmissions, but is associated with higher transfusion requirements, warranting careful consideration in surgical planning to ensure patient safety.

Original Source(s)

Concomitant Liver Biopsy During Bariatric Surgery: No Increase in Major Complications or Readmissions but Associated with Higher Transfusion Requirements - An Analysis of the MBSAQIP Database

  • by Juan S. Barajas-Gamboa, Kayanne Khoury, Valentin Mocanu, Mélissa V. Wills, Thomas H. Shin, Gustavo Romero-Velez, Matthew Allemang, Andrew T. Strong, Salvador Navarrete, Ricard Corcelles, A. Daniel Guerron, John Rodriguez, Matthew Kroh, Jerry T. Dang

  • September 25, 2025

Related Content

Postop Pain Differs by Vitamin D Status

Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.

Global Trends and Research Topics in Gastric Bypass Clinical Trials: A Bibliometric Analysis and Latent Dirichlet Allocation (LDA) Study

Estimating the Bariatric Surgery Rate in the Potentially Eligible Population within the Brazilian Public Healthcare System, 2017–2023